Melatonin: Difference between revisions

From Glioblastoma Treatments
Jump to navigationJump to search
(Blanked the page)
Tag: Blanking
No edit summary
Line 1: Line 1:
 
{{TreatmentInfo
|drug_name=Melatonin
|FDA_approval=No
|used_for=Jet lag, insomnia, various types of cancer including Glioblastoma Multiforme (GBM)
|clinical_trial_phase=Phase-2 and Phase-3 trials
|common_side_effects=No known toxic side effects
|OS_without=Not specified
|OS_with=Improved survival in some cancer treatments
|PFS_without=Not specified
|PFS_with=Not specified
|usefulness_rating=4
|notes=Melatonin is a hormone that regulates the body's diurnal rhythm and is used for the treatment of sleep disorders. In cancer treatment, it's hypothesized to boost the immune system, inhibit angiogenesis, and have direct cytotoxic effects on certain cancer cells. Clinical research, primarily in Italy, has explored its use alone or in combination with chemotherapy or immunotherapy, showing potential for increasing survival rates and reducing chemotherapy toxicity.
|category=Hormones
|links=
* [Relevant study or information link]
|toxicity_level=1
|toxicity_explanation=Melatonin is considered to have a low toxicity level, with no known toxic side effects. It is generally regarded as safe for use in the dosages typically administered for both sleep disorders and experimental cancer treatment protocols.
}}

Revision as of 09:21, 27 March 2024

Property Information
Drug Name Melatonin
FDA Approval No
Used for Jet lag, insomnia, various types of cancer including Glioblastoma Multiforme (GBM)
Clinical Trial Phase Phase-2 and Phase-3 trials
Clinical Trial Explanation Not specified
Common Side Effects No known toxic side effects
OS without Not specified
OS with Improved survival in some cancer treatments
PFS without Not specified
PFS with Not specified
Usefulness Rating 4
Usefulness Explanation Not specified
Toxicity Level 1
Toxicity Explanation Melatonin is considered to have a low toxicity level, with no known toxic side effects. It is generally regarded as safe for use in the dosages typically administered for both sleep disorders and experimental cancer treatment protocols.

Notes: Melatonin is a hormone that regulates the body's diurnal rhythm and is used for the treatment of sleep disorders. In cancer treatment, it's hypothesized to boost the immune system, inhibit angiogenesis, and have direct cytotoxic effects on certain cancer cells. Clinical research, primarily in Italy, has explored its use alone or in combination with chemotherapy or immunotherapy, showing potential for increasing survival rates and reducing chemotherapy toxicity.

Links: * [Relevant study or information link]

From Ben Williams Book: Not specified

Loading comments...